The autoimmunity in Graves's disease

Frontiers in Bioscience

Volumn 18, Issue 2, 2013, Pages 782-787

  Li, Hong ^a   Wang, Tao ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Graves' disease; IFN gamma; IL 2; Review

Indexed keywords

IMMUNOGLOBULIN G;

ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; IMMUNOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; TH1 TH2 BALANCE; TH17 CELL; THYROID GLAND;

ANIMALS; AUTOIMMUNITY; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULIN G; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE; TH17 CELLS; THYROID GLAND;

MLCS; MLOWN;

EID: 84878802431     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4141     Document Type: Review

References (48)

1. Taylor S. Graves of Graves' disease.1796-1853. J R Coll Physicians Lond 20(4), 298-300. (1986)
2. Chen MH, Chen MH, Liao SL, Chang TC, Chuang LM: Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 69(2), 332-7. (2008)
3. Paschke R, Ludgate M: The thyrotropin receptor in thyroid diseases. N Engl J Med 337(23), 1675-81. (1997)
4. Kohn LD, Shimojo N, Kohno Y, Suzuki K: An animal model of Graves' disease: understanding the cause of autoimmune hyperthyroidism. Rev Endocr Metab Disord 1(1-2), 59-67. (2000)
5. Brusko TM, AL Putnam, JA Bluestone: Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 223, 371-90. (2008) (Pubitemid 351986182)
6. Beissert S, A Schwarz, T Schwarz: Regulatory T cells. J Invest Dermatol 126(1), 15-24. (2006) (Pubitemid 43336089)
7. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6(4), 345-52. (2005) (Pubitemid 41716771)
8. Suzuki H, Kündig TM, Furlonger C, Wakeham A, Timms E: Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268(5216), 1472-6. (1995)
9. Suzuki H, Hayakawa A, Bouchard D, Nakashima I, Mak TW: Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice. Int Immunol 9(9), 1367-74. (1997) (Pubitemid 27389019)
10. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H: Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200(9), 1123-34. (2004) (Pubitemid 39507052)
11. Endharti AT, Rifa'I M, Shi Z, Fukuoka Y, Nakahara Y: Cutting edge: CD8+CD122+ regulatory T cells produce IL- 10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175 (11), 7093-7 (2005)
12. Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L: Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab 96(2), 422-9 (2010)
13. Marazuela M, García-López MA, Figueroa-Vega N, de la Fuente H: Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91(9), 3639-46 (2006) (Pubitemid 44402149)
14. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 99(7), 971-9 (2004) (Pubitemid 38481088)
15. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM: Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199(9), 1285-91. (2004) (Pubitemid 38620265)
16. Dhodapkar MV, RM Steinman: Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100(1), 174-7. (2002) (Pubitemid 35177444)
17. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H: Analysis of regulatory CD8 T cells in Qa-1- deficient mice. Nat Immunol 5(5), 516-23. (2004) (Pubitemid 38660464)
18. Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P: Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65(12), 5020-6. (2005)
19. Wei WZ, G.P. Morris, Y.C: Kong. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53(2), 73-8. (2004) (Pubitemid 38161212)
20. Wei WZ, Jacob JB, Zielinski JF, Flynn JC, Shim KD: Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice. Cancer Res 65(18), 8471-8. (2005)
21. Saitoh O, Abiru N, Nakahara M, Nagayama Y: CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model. Endocrinology 148(12), 6040-6. (2007)
22. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7), 2348-57. (1986) (Pubitemid 16136806)
23. Mosmann TR, RL Coffman: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145-73. (1989) (Pubitemid 19138011)
24. Nicholson LB, VK Kuchroo: Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 8(6), 837-42. (1996) (Pubitemid 27007650)
25. Del Prete GF, Tiri A, Mariotti S, Pinchera A, Ricci M, Romagnani S: Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin Exp Immunol 69(2), 323-31. (1987) (Pubitemid 17154241)
26. Del Prete GF, Tiri A, De Carli M, Mariotti S, Pinchera A: High potential to tumor necrosis factor alpha (TNF-alpha) production of thyroid infiltrating T lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity. Autoimmunity 4(4), 267-76. (1989) (Pubitemid 19261058)
27. Ajjan RA, Watson PF, McIntosh RS, Weetman AP: Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol 105(3), 523-8. (1996) (Pubitemid 26297900)
28. Nielsen CH, Hegedüs L, Rieneck K, Moeller AC, Leslie RG, Bendtzen K: Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 147(2), 287-95. (2007) (Pubitemid 46096007)
29. García-López MA, Sancho D, Sánchez-Madrid F, Marazuela M: Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86(10), 5008-16. (2001) (Pubitemid 33020557)
30. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M: Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP- 10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 161(1), 195-206. (2002) (Pubitemid 34760785)
31. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF: Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59(2), 207-13. (2003) (Pubitemid 36918657)
32. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM: High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89(11),5496-9. (2004)
33. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM: Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152(2), 171-7. (2005) (Pubitemid 40309561)
34. Berger JP, TE Akiyama, PT Meinke: PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26(5), 244-51. (2005) (Pubitemid 40603072)
35. Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C: CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes. J Clin Endocrinol Metab 95(12), E413-20. (2010)
36. Molnar I. The balance shift in Th1/Th2 related IL- 12/IL-5 cytokines in Graves' disease during methimazole therapy. Autoimmunity 40(1), 31-7. (2007) (Pubitemid 46332420)
37. Itoh M, Uchimura K, Hayakawa N, Makino M, Hayashi R, Nagata M, Kakizawa H, Nagasaka A, Sakamoto H, Kuzuya H: Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD). Clin Exp Immunol 113(2), 309-14. (1998) (Pubitemid 28352852)
38. Watanabe M, Amino N, Hochito K, Watanabe K, Kuma K, Iwatani Y: Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases. Thyroid 7(5), 743-7. (1997) (Pubitemid 28086205)
39. Bossowski A, M Urban, A Stasiak-Barmuta: Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J Pediatr Endocrinol Metab 16(1), 63-70. (2003) (Pubitemid 37259094)
40. Aust G, Lehmann I, Heberling HJ: Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease. Exp Clin Endocrinol Diabetes 104(1), 50-8. (1996)
41. Kumar S, Bahn RS: Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy. J Clin Endocrinol Metab 88(9), 4246-50. (2003) (Pubitemid 37153727)
42. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF: TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58(3), 280-7. (2003) (Pubitemid 36308115)
43. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell133(5), 775-87. (2008) (Pubitemid 351707693)
44. Chen X, Oppenheim JJ: TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr Dir Autoimmun 11, 119-34. (2010)
45. Zhou L, Chong MM, Littman DR.: Plasticity of CD4+ T cell lineage differentiation. Immunity 30(5), 646-55. (2009)
46. Weetman, A.P. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol (Oxf) 61(4), 405-13.(2004) (Pubitemid 39388475)
47. Outschoorn IM, Talor MV, Hoffman WH, Rowley MJ, Mackay IR, Rose NR, Burek CL: Autoantibody heritability in thyroiditis: IgG subclass contributions. Autoimmunity 44(3), 195-200. (2010)
48. Santoh T, Watanabe M, Kuroda S, Ueda D, Iwatani Y: Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease. Endocr J 54(6), 887-94. (2007) (Pubitemid 351346771)